Evidence map›Paper›PMID 23392457›Full record

ArticleJournal of acquired immune deficiency syndromes (1999)2013

Mortality associated with delays between clinic entry and ART initiation in resource-limited settings: results of a transition-state model.

Christopher J Hoffmann, James J Lewis, David W Dowdy, Katherine L Fielding, Alison D Grant, Neil A Martinson, Gavin J Churchyard, Richard E Chaisson

Abstract read
In one paragraph

Article in Journal of acquired immune deficiency syndromes (1999), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Better adherence to pre-antiretroviral therapy guidelines after implementing an electronic medical record system in rural Kenyan HIV clinics: a multicenter pre-post study.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2015
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Christopher J HoffmannDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA. choffmann@jhmi.edu
James J Lewis
David W Dowdy
Katherine L Fielding
Alison D Grant
Neil A Martinson
Gavin J Churchyard
Richard E Chaisson

Funding

Vaccine Response and Immunotherapeutics SWGP30AI094189 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Richard E. Chaisson · 2012 to 2026
$67.0M
Longitudinal Study of HIV-Associated Lung Infections in SowetoR01HL090312 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI CHAISSON, RICHARD E. · 2007 to 2012
$3.3M
DOT-HAART for HIV-Infected South African AdultsR01AI055359 · NIAID · JOHNS HOPKINS UNIVERSITY · PI CHAISSON, RICHARD E. · 2003 to 2008
$2.6M
Environmental Modulation of Epigenetic Reprogramming in Pluripotent CellsR01OD012204 · OD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI RAMALHO-SANTOS, MIGUEL · 2012 to 2016
$1.9M
Regulation of developmental potency by the transposon LINE1R01GM123556 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MCMANUS, MICHAEL T · 2017 to 2020
$1.6M
CAUSES OF AND ASSOCIATIONS WITH DEATH DURING LONG TERM HAART IN AFRICAK23AI083099 · NIAID · JOHNS HOPKINS UNIVERSITY · PI HOFFMANN, CHRISTOPHER J · 2010 to 2014
$671k
Medical Research Council MR/K007467/1Medical Research Council MR/K012126/1NHLBI NIH HHS HL090312NHLBI NIH HHS R01 HL090312NIAID NIH HHS AI083099NIAID NIH HHS AI5535901NIAID NIH HHS K23 AI083099NIAID NIH HHS P30 AI094189NIAID NIH HHS P30-AI094189-01A1NIGMS NIH HHS R01 GM123556NIH HHS R01 OD012204
6 · The paper itself

Abstract

objectiveTo estimate the mortality impact of delay in antiretroviral therapy (ART) initiation from the time of entry into care.

designA state-transition Markov process model. This technique allows for assessing mortality before and after ART initiation associated with delays in ART initiation among a general population of ART-eligible patients without conducting a randomized trial.

methodsWe used patient-level data from 3 South African cohorts to determine transition probabilities for pre-ART CD4 count changes and pre-ART and on-ART mortality. For each parameter, we generated probabilities and distributions for Monte Carlo simulations with 1-week cycles to estimate mortality 52 weeks from clinic entry.

resultsWe estimated an increase in mortality from 11.0% to 14.7% (relative increase of 34%) with a 10-week delay in ART for patients entering care with our pre-ART cohort CD4 distribution. When we examined low CD4 ranges, the relative increase in mortality delays remained similar; however, the absolute increase in mortality rose. For example, among patients entering with CD4 count 50-99 cells per cubic millimeter, 12-month mortality increased from 13.3% with no delay compared with 17.0% with a 10-week delay and 22.9% with a 6-month delay.

conclusionsDelays in ART initiation, common in routine HIV programs, can lead to important increases in mortality. Prompt ART initiation for patients entering clinical care and eligible for ART, especially those with lower CD4 counts, could be a relatively low-cost approach with a potential marked impact on mortality.

Indexed as

Monte Carlo MethodAmbulatory Care FacilitiesAnti-HIV AgentsCD4 Lymphocyte CountFemaleHIV InfectionsHumansMaleSouth AfricaSurvival AnalysisSurvival RateTime FactorsAnti-HIV Agents

Identifiers

PMID23392457
PMCPMC3647455

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.